Hypertension in Cardio-Oncology Clinic: an update on etiology, assessment, and management
Abstract Hypertension is one of the most common comorbidity and the leading cause of cancer-related death in cancer patients. The prevalence of hypertension in cancer patients is much higher than that of the general population. In the older population of cancer patients, specific cancer treatments s...
Main Authors: | Amir Askarinejad, Azin Alizadehasl, Amir Ghaffari Jolfayi, Sara Adimi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Cardio-Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40959-023-00197-8 |
Similar Items
-
Etiology and management of hypertension in patients with cancer
by: Turab Mohammed, et al.
Published: (2021-04-01) -
Vascular endothelial growth factor-tyrosine kinase inhibitors: Novel mechanisms, predictors of hypertension and management strategies
by: Javier A. Gomez
Published: (2022-05-01) -
Hypertensive Cardiotoxicity in Cancer Treatment—Systematic Analysis of Adjunct, Conventional Chemotherapy, and Novel Therapies—Epidemiology, Incidence, and Pathophysiology
by: Robin Chung, et al.
Published: (2020-10-01) -
Cardio-Oncology in Iran: Cardio-toxicity Registry
by: Azin Alizadehasl, et al.
Published: (2022-08-01) -
Association between baseline blood pressure and the incidence of lenvatinib‐induced hypertension in patients with thyroid cancer
by: Yuma Shibutani, et al.
Published: (2023-11-01)